1. Home
  2. CALC vs GDO Comparison

CALC vs GDO Comparison

Compare CALC & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CalciMedica Inc.

CALC

CalciMedica Inc.

HOLD

Current Price

$0.61

Market Cap

88.3M

Sector

Health Care

ML Signal

HOLD

Logo Western Asset Global Corporate Defined Opportunity Fund Inc.

GDO

Western Asset Global Corporate Defined Opportunity Fund Inc.

HOLD

Current Price

$10.66

Market Cap

86.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
CALC
GDO
Founded
2011
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
88.3M
86.7M
IPO Year
2020
2009

Fundamental Metrics

Financial Performance
Metric
CALC
GDO
Price
$0.61
$10.66
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
444.5K
30.4K
Earning Date
03-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$10.29
52 Week High
$7.20
$12.15

Technical Indicators

Market Signals
Indicator
CALC
GDO
Relative Strength Index (RSI) 32.40 21.73
Support Level $0.49 N/A
Resistance Level $0.79 $11.71
Average True Range (ATR) 0.08 0.11
MACD 0.06 -0.02
Stochastic Oscillator 8.44 4.00

Price Performance

Historical Comparison
CALC
GDO

About CALC CalciMedica Inc.

CalciMedica Inc is a clinical-stage biopharmaceutical company focused on developing therapeutics that treat serious illnesses driven by inflammatory and immunologic processes and direct cellular damage. Its product candidates act upon calcium release-activated calcium (CRAC) channels and would constitute a new class of drugs. Its product candidate is Auxora, a potent and selective intravenous formulated small molecule CRAC channel inhibitor containing the active compound zegocractin (formerly referred to as CM4620) that, in animal models, reduced acute epithelial and/or endothelial cell injury and inflammation in organs, such as the pancreas, lungs and kidneys.

About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.

Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.

Share on Social Networks: